Loading…
Loading…
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.
Shares of BrightSpring Health Services, Inc. (NASDAQ: BTSG - Get Free Report) have been assigned an average recommendation of "Buy" from the twenty research firms that are covering the company, Marketbeat.com reports. Eighteen equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The
William Blair reshuffled its September stock picks, bringing eight companies onto its Analyst Conviction List as the firm identified several new opportunities a
Canada Pension Plan Investment Board purchased a new position in BrightSpring Health Services, Inc. (NASDAQ: BTSG) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 51,300 shares of the company's stock, valued at approximately $3,578,000. Other large investors have
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.
BTSG, OPHC, HRTG, UMC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on August 26th, 2026.
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.